Novel antibody against brain tumors

0

(Helmholtz Zentrum München – German Research Center for Environmental Health) Scientists of Helmholtz Zentrum München and the Munich University Hospital (LMU) are developing a novel antibody to treat brain tumors. Now, with funding amounting to EUR 3.5 million approved by the Federal Ministry of Education and Research (BMBF) and the Helmholtz Validation Fund, the molecule shall undergo the first phase of clinical testing.

Leave A Reply

Your email address will not be published.